当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
COVID-19 and Anti-CD14 Treatment Trial
标题(英文)
COVID-19 and Anti-CD14 Treatment Trial
条件
Coronavirus Disease 2019 (COVID-19)|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
干预
Biological: anti-CD14|Other: Placebo|Drug: remdesivir